FEDERATED HERMES, INC. - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 51 filers reported holding APREA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.0%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$746
-62.7%
2,253
-35.0%
0.00%
Q3 2022$2,000
-33.3%
3,465
-6.1%
0.00%
Q2 2022$3,000
-57.1%
3,691
+3.9%
0.00%
Q1 2022$7,000
-30.0%
3,554
+1.4%
0.00%
Q4 2021$10,000
-9.1%
3,505
+62.8%
0.00%
Q3 2021$11,000
+22.2%
2,153
+17.1%
0.00%
Q2 2021$9,000
+800.0%
1,838
+2037.2%
0.00%
Q1 2021$1,000860.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,259,662$6,437,0002.66%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$214,0000.30%
Redmile Group, LLC 694,918$3,551,0000.06%
Quantamental Technologies LLC 13,752$70,0000.05%
KENNEDY CAPITAL MANAGEMENT LLC 342,486$1,750,0000.04%
PDT Partners, LLC 87,734$448,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$383,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,100$251,0000.01%
NEXT Financial Group, Inc 11,347$58,0000.01%
Sugarloaf Wealth Management, LLC 1,500$8,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders